Brown Advisory Inc. Purchases 26,069 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Brown Advisory Inc. lifted its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 1.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,931,163 shares of the company's stock after buying an additional 26,069 shares during the period. Brown Advisory Inc. owned about 4.20% of Avanos Medical worth $27,674,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in AVNS. Quantbot Technologies LP bought a new position in Avanos Medical during the fourth quarter valued at approximately $64,000. State of Wyoming increased its holdings in Avanos Medical by 132.0% during the fourth quarter. State of Wyoming now owns 5,137 shares of the company's stock valued at $82,000 after buying an additional 2,923 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in Avanos Medical by 493.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock valued at $129,000 after buying an additional 6,714 shares during the last quarter. Heritage Family Offices LLP purchased a new stake in Avanos Medical during the first quarter valued at approximately $146,000. Finally, EP Wealth Advisors LLC increased its stake in shares of Avanos Medical by 14.6% in the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after purchasing an additional 1,289 shares in the last quarter. Institutional investors own 95.17% of the company's stock.

Avanos Medical Price Performance

AVNS traded down $0.32 during trading on Friday, hitting $11.95. 309,333 shares of the company traded hands, compared to its average volume of 386,468. The company has a market cap of $552.38 million, a PE ratio of -1.43 and a beta of 1.12. The stock's 50-day simple moving average is $12.42 and its two-hundred day simple moving average is $13.99. Avanos Medical, Inc. has a 1 year low of $11.68 and a 1 year high of $25.36. The company has a current ratio of 2.57, a quick ratio of 1.56 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. The company had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. Avanos Medical had a negative net margin of 55.80% and a positive return on equity of 6.26%. Avanos Medical's quarterly revenue was up .8% on a year-over-year basis. During the same period last year, the company posted $0.22 earnings per share. As a group, sell-side analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Avanos Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, March 19th.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.